A

SEC EDGAR - Form 4 insider activity

Agomab Therapeutics NV $AGMB

Tracked equity - 4 filings indexed by Nortis

Nortis signal thesis

Cluster activity detected. Review whether the filings are open-market trades or routine compensation events.

4

OM buys - 90d

0

OM sells - 90d

0

Routine filings

4

Cluster filings

$50.9K

Largest trade

85/100

Avg signal score

Filing tape

Recent filings

Last 30d: 4
Open-market BuyCLUSTERHigh signal 85/100
filed 2026-10-09
ERBoard

Epstein David R - Director - $44.5K

Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Open-market BuyCLUSTERHigh signal 85/100
filed 2026-10-07
ERBoard

Epstein David R - Director - $42.9K

Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Open-market BuyCLUSTERHigh signal 85/100
filed 2026-10-07
KVCFO

Kemula Pierre Thadee Victor - Chief Financial Officer - $26.0K

Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Open-market BuyCLUSTERHigh signal 85/100
filed 2026-10-07
KJCEO

Knotnerus Tim Jasper - Director, Chief Executive Officer - $50.9K

Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing